Quantcast
Last updated on April 17, 2014 at 15:50 EDT

Latest Myelin Stories

2012-04-18 10:25:03

Findings released "indicate that it is possible to identify neuroinflammation at the time of birth and to treat it using anti-inflammatory agents coupled with nanodevices," says Dr. Roberto Romero, Chief of the Perinatology Research Branch, NICHD/NIH DETROIT, April 18, 2012 /PRNewswire-USNewswire/ -- Researchers at the Perinatology Research Branch of the National Institutes of Health, housed at the Wayne State University School of Medicine and the Detroit Medical Center, have...

2012-03-27 11:54:22

Intravenous immune globulin (IVIg) is an effective treatment for certain disorders of the nerve and muscles, including Guillain-Barré syndrome (GBS) and a form of neuropathy called chronic inflammatory demyelinating polyneuropathy (CIDP), according to a guideline issued by the American Academy of Neurology. The guideline is published in the March 27, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. IVIg is a type of immunotherapy...

2012-02-27 11:09:40

Millions of adults suffer from the incurable disease multiple sclerosis (MS). It is relatively certain that MS is an autoimmune disease in which the body's own defense cells attack the myelin in the brain and spinal cord. Myelin enwraps the nerve cells and is important for their function of transmitting stimuli as electrical signals. There are numerous unconfirmed hypotheses on the development of MS, one of which has now been refuted by the neuroimmunologists in their current research: The...

2012-02-08 11:19:00

SARATOGA, Calif. and MEQUON, Wis., Feb. 8, 2012 /PRNewswire/ -- The Myelin Repair Foundation (MRF) and ENDECE Neural, LLC have formed a partnership to expedite the advancement of myelin regeneration drug candidates for Multiple Sclerosis (MS) patients through pre-clinical studies and into Phase I clinical studies. Through this unique collaboration, the newly launched MRF Translational Medicine Center will assess the myelin regenerating capabilities of proprietary small molecule...

2012-01-11 06:35:56

(Ivanhoe Newswire)-- Recent studies give hope for patients with the irreversible disease known as MS or multiple sclerosis by possibly reversing the aging effects of the central nervous system. Approximately 100,000 people in the United Kingdom, 400,000 in the United States and several million worldwide are affected by MS. With age our bodies' regenerative abilities decrease. While wrinkles allow us to see visible aging effects of skin many other body tissues are left invisibly aging....

2012-01-06 15:13:06

Proof of principle study suggests the age-associated decline of the remyelination process is reversible New research highlights the possibility of reversing ageing in the central nervous system for multiple sclerosis (MS) patients. The study is published today, 06 January, in the journal Cell Stem Cell. As we get older, our bodies' ability to regenerate decreases. This is not only true for our skin (which is evident in the wrinkles that develop as we age) but also true for other tissues...

2012-01-06 15:11:48

Proof-of-principle study provides hope for stimulating remyelination Scientists at Joslin Diabetes Center, Harvard University, and the University of Cambridge have found that the age-related impairment of the body's ability to replace protective myelin sheaths, which normally surround nerve fibers and allow them to send signals properly, may be reversible, offering new hope that therapeutic strategies aimed at restoring efficient regeneration can be effective in the central nervous system...

2012-01-05 14:43:33

New laboratory approach could aid brain recovery, TAU research finds In humans, active periods of the debilitating disease Multiple Sclerosis (MS) can last for mere minutes or extend to weeks at a time. They're caused by lesions in the brain that develop, partly heal, and then recur. Research into a cure has been difficult, because to date scientists have not been able to replicate these brain recurring symptoms in laboratory mice. That's frustrating because these lab animals, known as...

2011-12-02 13:55:30

Mayo Clinic researchers have identified critical steps leading to myelin destruction in neuromyelitis optica (NMO), a debilitating neurological disease that is commonly misdiagnosed as multiple sclerosis (MS). The findings could lead to better care for the thousands of patients around the world with NMO. The paper was published in the journal, Proceedings of the National Academy of Sciences, USA. NMO is an inflammatory autoimmune disease of the central nervous system that damages the optic...

2011-11-15 20:58:51

Findings suggest new treatments to limit damage from stroke, very premature birth New research released today demonstrates the brain's remarkable capacity to repair itself. The animal studies, which propose ways to prevent or limit damage after blood and oxygen deprivation and blood clots, were presented at Neuroscience 2011, the Society for Neuroscience's annual meeting and the world's largest source of emerging news about brain science and health. Stroke is the number one cause of...